Both LINC00152 and FSCN have binding sites for three miRNAs, so two of them (miR-185-3p and miR-632) have more regulatory effect on FSCN1 and significantly lower expressions in the CRC tumor tissue compared to normal adjacent tissue. The gene discussed is FSCN1; the disease is colorectal carcinoma.